![Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - - Clinical Pharmacology in Drug Development - Wiley Online Library Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - - Clinical Pharmacology in Drug Development - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/1eab5d75-9e83-4f7e-8ad1-305c8b5777c0/cpdd1050-fig-0001-m.jpg)
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - - Clinical Pharmacology in Drug Development - Wiley Online Library
![Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-43224-4/MediaObjects/41598_2019_43224_Fig1_HTML.png)
Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation | Scientific Reports
![ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries - European Journal of Internal Medicine ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries - European Journal of Internal Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/11b6b198-ad16-4020-af28-bf89ce9b98a3/gr1.jpg)
ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries - European Journal of Internal Medicine
![Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation | Journal of the American College of Cardiology Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/1f45932f-aaf9-4314-844f-9341568eff58/fx1.jpg)
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation | Journal of the American College of Cardiology
![Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/ce1d741f-6a97-4d25-a617-8b33d22a40e6/fx1.jpg)
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology
![Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement](https://scx2.b-cdn.net/gfx/news/2021/edoxaban-may-be-effect.jpg)
Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement
Missouri Society of Health-System Pharmacists - Pharmacist Continuing Education: From DOACs to ROACs: Strategies for Reversing Oral Anticoagulants
![Abstract 17950: High-Dose Edoxaban Regimen versus Warfarin in Patients With Atrial Fibrillation and Established Coronary Artery Disease: Insights From the ENGAGE AF-TIMI 48 Trial | Circulation Abstract 17950: High-Dose Edoxaban Regimen versus Warfarin in Patients With Atrial Fibrillation and Established Coronary Artery Disease: Insights From the ENGAGE AF-TIMI 48 Trial | Circulation](https://www.ahajournals.org/cms/asset/ef00a8a7-8419-4ede-9729-4c85b9b12423/g17950.gif)